- Report
- March 2023
- 80 Pages
France
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 80 Pages
China
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 80 Pages
Brazil
From €1426EUR$1,500USD£1,198GBP
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 80 Pages
South Korea
From €1426EUR$1,500USD£1,198GBP
- Report
- October 2024
- 100 Pages
Romania
From €2675EUR$3,014USD£2,326GBP
- Report
- October 2024
- 81 Pages
Uruguay
From €2675EUR$3,014USD£2,326GBP
- Report
- October 2024
- 94 Pages
Nigeria
From €2675EUR$3,014USD£2,326GBP
- Report
- September 2024
- 105 Pages
Portugal
From €2675EUR$3,014USD£2,326GBP
- Report
- September 2024
- 105 Pages
Greece
From €2675EUR$3,014USD£2,326GBP
- Report
- September 2024
- 109 Pages
Malaysia
From €2675EUR$3,014USD£2,326GBP
- Report
- September 2024
- 105 Pages
Colombia
From €2675EUR$3,014USD£2,326GBP
- Report
- September 2024
- 101 Pages
Vietnam
From €2675EUR$3,014USD£2,326GBP
- Report
- September 2024
- 118 Pages
Italy
From €2675EUR$3,014USD£2,326GBP
- Report
- September 2024
- 25 Pages
Italy
From €995EUR$1,121USD£865GBP
- Report
- September 2024
- 26 Pages
France
From €995EUR$1,121USD£865GBP
- Report
- January 2024
- 302 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Database
- July 2023
Global
From €342EUR$360USD£288GBP
- Report
- April 2023
- 65 Pages
India
- Report
- September 2021
- 119 Pages
Russia
From €2200EUR$2,479USD£1,913GBP

The Antacid market is a segment of the Over the Counter (OTC) Drugs industry. Antacids are used to treat symptoms of acid reflux, heartburn, and indigestion. They are available in a variety of forms, including tablets, liquids, and chewable gummies. Antacids are generally safe and effective, and can be purchased without a prescription.
The Antacid market is highly competitive, with a wide range of products available from both large and small companies. Many of the products are marketed as being fast-acting and long-lasting, and some are formulated to provide additional benefits such as relief from gas and bloating.
Some of the companies in the Antacid market include GlaxoSmithKline, Pfizer, Bayer, Johnson & Johnson, Novartis, and Procter & Gamble. Show Less Read more